Access to COVID-19 Vaccines and Medicines - a Global Public Good
Abstract: New daily record numbers of infections worldwide exacerbate concerns about the impact of the COVID-19 pandemic on regions of the Global South. Weak health systems, vulnerable economies, and extreme inequalities threaten healthcare, livelihoods, and peace in many low- and middle-income countries. The risk of increasing infection rates remains imminent for all countries until a vaccine or medicine is available to everyone worldwide. While many low-income countries urgently need to "flatten the curve", rigid lockdown measures are difficult to impose in the vast informal sector and can mean a more imminent threat to lives and livelihoods by depriving millions of income and food. COVID-19 has already led to a world economic crisis through the breakdown of trade and rapidly increasing debts, and will only aggravate global inequalities even further. The key for slowing and eventually stopping the pandemic without lockdowns lies in the development of, and universal access to, effective dru
- Weitere Titel
-
Zugang zu COVID-19-Impfstoffen und Medikamenten: Ein globales öffentliches Gut
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 13 S.
- Sprache
-
Englisch
- Anmerkungen
-
Veröffentlichungsversion
begutachtet
- Erschienen in
-
GIGA Focus Global ; Bd. 4
- Klassifikation
-
Wirtschaft
- Ereignis
-
Veröffentlichung
- (wo)
-
Mannheim
- (wer)
-
SSOAR, GESIS – Leibniz-Institut für Sozialwissenschaften e.V.
- (wann)
-
2020
- Ereignis
-
Veröffentlichung
- (wo)
-
Hamburg
- (wer)
-
GIGA German Institute of Global and Area Studies - Leibniz-Institut für Globale und Regionale Studien
- (wann)
-
2020
- Urheber
- Beteiligte Personen und Organisationen
-
GIGA German Institute of Global and Area Studies - Leibniz-Institut für Globale und Regionale Studien
- URN
-
urn:nbn:de:0168-ssoar-68332-2
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hein, Wolfgang
- Harant, Anne
- GIGA German Institute of Global and Area Studies - Leibniz-Institut für Globale und Regionale Studien
- SSOAR, GESIS – Leibniz-Institut für Sozialwissenschaften e.V.
Entstanden
- 2020
Ähnliche Objekte (12)
COVID-19 vaccines as global public goods: Between life and profit
Innovation and patenting activities of COVID-19 vaccines in WTO members: Analytical review of Medicines Patent Pool (MPP) COVID-19 Vaccines Patent Landscape (VaxPaL)
Guidelines on patentability and access to medicines
Access to innovative oncology medicines in Europe
Access of high technology medicines in Russia
Global access to COVID-19 vaccines: Challenges in production, affordability, distribution and utilisation
Global access to COVID-19 vaccines: challenges in production, affordability, distribution and utilisation
Medicines and vaccines supply chains challenges in Nigeria: a scoping review
Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives
Framing access to medicines in developing countries: an analysis of media coverage of Canada's Access to Medicines Regime
COVID-19 Vaccines: A Radiological Review of the Good, the Bad, and the Ugly
Strengthening access to medicines through transparency and accountability
COVID-19 vaccines as global public goods: Between life and profit
Innovation and patenting activities of COVID-19 vaccines in WTO members: Analytical review of Medicines Patent Pool (MPP) COVID-19 Vaccines Patent Landscape (VaxPaL)
Guidelines on patentability and access to medicines
Access to innovative oncology medicines in Europe
Access of high technology medicines in Russia
Global access to COVID-19 vaccines: Challenges in production, affordability, distribution and utilisation
Global access to COVID-19 vaccines: challenges in production, affordability, distribution and utilisation
Medicines and vaccines supply chains challenges in Nigeria: a scoping review
Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives
Framing access to medicines in developing countries: an analysis of media coverage of Canada's Access to Medicines Regime
COVID-19 Vaccines: A Radiological Review of the Good, the Bad, and the Ugly
Strengthening access to medicines through transparency and accountability
COVID-19 vaccines as global public goods: Between life and profit
Innovation and patenting activities of COVID-19 vaccines in WTO members: Analytical review of Medicines Patent Pool (MPP) COVID-19 Vaccines Patent Landscape (VaxPaL)
Guidelines on patentability and access to medicines
Access to innovative oncology medicines in Europe
Access of high technology medicines in Russia
Global access to COVID-19 vaccines: Challenges in production, affordability, distribution and utilisation
Global access to COVID-19 vaccines: challenges in production, affordability, distribution and utilisation
Medicines and vaccines supply chains challenges in Nigeria: a scoping review
Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives
Framing access to medicines in developing countries: an analysis of media coverage of Canada's Access to Medicines Regime
COVID-19 Vaccines: A Radiological Review of the Good, the Bad, and the Ugly